Search for stock quotes, financial statistics and more
TD Cowen analyst David Kwan maintained a “Buy” rating and C$7.50 target price on WELL Health Tec... Read More
Stifel analyst Justin Keywood maintained his “Buy” rating and $9.00 target price on WELL Health... Read More
Paradigm Capital analyst Daniel Rosenberg maintained his “Buy” rating and raised his 12-month ta... Read More
Stifel Research analyst Justin Keywood maintained a “Buy” rating on WELL Health Technologies (WE... Read More
Following an update on its Canadian clinics business, Raymond James analyst Michael W. Freeman remai... Read More
Share
Tweet
pin
Share